Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Vlassara

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|May 5, 1995
Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptorR Bucala, R Mitchell, K Arnold, et al.
Kidney International|October 24, 2000
Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal diseaseC J He, F Zheng, A Stitt, et al.
The Journal of Experimental Medicine|October 1, 1991
Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathyE Y Skolnik, Z Yang, Z Makita, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and agingM Kirstein, J Brett, S Radoff, et al.
Science (New York, N.Y.)|June 10, 1988
Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelingH Vlassara, M Brownlee, K R Manogue, et al.
Journal of the Neurological Sciences|December 14, 1999
A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: immunohistochemical studyS M Chou, C Y Han, H S Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiencyR Bucala, Z Makita, G Vega, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domainsA W Stitt, G A Burke, F Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factorT Doi, H Vlassara, M Kirstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 1994
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal ratsH Vlassara, L J Striker, S Teichberg, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|May 5, 1995
Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptorR Bucala, R Mitchell, K Arnold, et al.
Kidney International|October 24, 2000
Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal diseaseC J He, F Zheng, A Stitt, et al.
The Journal of Experimental Medicine|October 1, 1991
Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathyE Y Skolnik, Z Yang, Z Makita, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and agingM Kirstein, J Brett, S Radoff, et al.
Science (New York, N.Y.)|June 10, 1988
Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelingH Vlassara, M Brownlee, K R Manogue, et al.
Journal of the Neurological Sciences|December 14, 1999
A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: immunohistochemical studyS M Chou, C Y Han, H S Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiencyR Bucala, Z Makita, G Vega, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domainsA W Stitt, G A Burke, F Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factorT Doi, H Vlassara, M Kirstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 1994
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal ratsH Vlassara, L J Striker, S Teichberg, et al.
Pageof 12